Gold Health Tech Gold Health Tech
search
Medical equipment zoom_in Select an image to inspect
Available for inquiry Specification-led inquiry

Medical equipment sourcing

Genetic Mutation Test Kit

Reference: 731006Laboratory Medicine
Sample TypeFfpe Tissues, Cell
ApplicationsFor Genetic Mutations, For Lung Cancer, For Genotyping, For Pharmacogenetics
Analysis ModeLateral Flow, Enzymatic, For Pcr, Dna Analysis
Tested ParameterFor Genes
request_quote Request product information Back to catalog

Associated tags

For Lung CancerFor GenotypingFor Pharmacogenetics
manage_search

Product fit review

Compare the available product information with your application and purchasing requirements.

description

Documentation request

Ask which specifications, manuals, or commercial documents are available for review.

support_agent

Supplier coordination

Discuss quantity, destination, packaging, and timing before confirming suitability.

support_agent Request info description

Product information

Product summary

The response to EGFR tyrosine kinase inhibitor (TKI) therapies is predicted by mutations in the epidermal growth factor receptor (EGFR) gene. The ViennaLab StripAssay® identifies 30 EGFR mutations that are pertinent to the development of TKI therapies for non-small cell lung cancer (NSCLC).input:
output:NSCLC accounts for approximately 85% of all lung cancers. Prior to the administration of TKIs, tumor specimens from patients should be examined for the presence of EGFR mutations.input:
output:Patients with EGFR mutations, which are referred to as "activating mutations," may benefit from first-, second-, or third-generation TKIs. Treatment with third-generation TKIs may be advantageous for patients who possess the EGFR T790M resistance mutation.input:
output:The EGFR XL StripAssay® is intended to aid clinicians in the stratification of patients who are being examined for TKI therapy.

Continue your equipment review

Related products